Resisting antimicrobial resistance

To control antimicrobial resistance (AMR) will require approaches to develop, share and preserve antibiotics that are scaled to the scientific, economic and ethical dimensions of the crisis. The three cooperative, interdisciplinary, international councils proposed here exemplify what this will require.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Roope, L. S. J. et al. The challenge of antimicrobial resistance: what economics can contribute. Science 364, eaau4679 (2019).

  2. 2.

    The Review on Antimicrobial Resistance. Tackling drug-resistant infections globally: final report and recommendations. (2016).

  3. 3.

    Nathan, C. & Cars, O. Antibiotic resistance — problems, progress, and prospects. N. Engl. J. Med. 371, 1761–1763 (2014).

  4. 4.

    Laxminarayan, R., Sridhar, D., Blaser, M., Wang, M. & Woolhouse, M. Achieving global targets for antimicrobial resistance. Science 353, 874–875 (2016).

  5. 5.

    Nathan, C. Aligning pharmaceutical innovation with medical need. Nat. Med. 13, 304–308 (2007).

  6. 6.

    Nielsen, T. B., Brass, E. P., Gilbert, D. N., Bartlett, J. G. & Spellberg, B. Sustainable discovery and development of antibiotics - is a nonprofit approach the future? N. Engl. J. Med. 381, 503–505 (2019).

  7. 7.

    Outterson, K. et al. Delinking investment in antibiotic research and development from sales revenues: the challenges of transforming a promising idea into reality. PLoS Med. 13, e1002043 (2016).

  8. 8.

    Årdal, C. et al. Drive-AB Report. Revitalizing the antibiotic pipeline. (2018).

  9. 9.

    Barbier, E. Sustainability: tax ‘societal ills’ to save the planet. Nature 483, 30 (2012).

  10. 10.

    Nathan, C. F. Cooperative development of antimicrobials: looking back to look ahead. Nat. Rev. Microbiol. 13, 651–657 (2015).

Download references

Author information



Corresponding author

Correspondence to Carl Nathan.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Related links

Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X):

Global Antibiotic Research and Development Partnership (GARDP):

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nathan, C. Resisting antimicrobial resistance. Nat Rev Microbiol 18, 259–260 (2020).

Download citation

Further reading